AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Evolution of MDS and AML classifications and their clinical impact
This chapter explores the development of classifications for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), from the morphological-based FAB system to the more genetically defined WHO classification. It discusses the overlap and differences between the two systems and their implications for treatment decisions.